摘要
目的探讨CT在宫颈癌术前新辅助化疗评估中的应用价值。方法 46例失去手术指征的宫颈癌患者,经两个疗程顺铂+紫杉醇化疗方案治疗后进行CT平扫加增强检查,参照WHO实体瘤疗效评价标准进行CT评估。结果本组化疗有效38例,肿瘤与侵犯脏器解剖关系有效改善36例,重新获得手术机会14例,转为其它方式治疗32例。结论CT对宫颈癌新辅助化疗效果的评估具有重要的临床价值,可以作为临床重要的评估手段。
Objective To explore the clinical value of CT in the assessment of neoadjuvant chemotherapy on cervical cancer.Methods A total of 46 patients with cervical cancer,without surgical indications,were treated with two courses of cisplatin and paclitaxel chemotherapy.After therapy,a CT scan plus enhanced was done,with reference to the WHO in solid tumors response evaluation criteria for CT evaluation.Results 38 cases were effective,36 cases showing effective improvement on tumors with violations of the organ anatomical relationship,14 cases regaining surgery opportunity,and 32 cases converting other treatments.Conclusion CT has important clinical value in the assessment of neoadjuvant chemotherapy on cervical cancer before surgery.
出处
《四川医学》
CAS
2013年第7期1090-1092,共3页
Sichuan Medical Journal
关键词
CT
新辅助化疗
宫颈癌
CT
neoadjuvant chemotherapy
cervical cancer
